Harrington RL, et al. - Utilizing the Truven Health MarketScan (r) Commercial Claims and Encounters database (2009-2014), researchers undertook this observational cohort analysis to determine the types and combinations of chronic conditions experienced by pediatric cancer survivors in the years immediately following the completion of cancer treatment. They examined early pediatric cancer survivors (children who were ≥ 2 years from the end of treatment and aged ≤ 18 years). Of 3,687 early survivors identified, about 41.2% had no chronic conditions, and 22.5% and 36.3% had 1 chronic condition and ≥2 chronic conditions, respectively. Findings revealed that pediatric cancer survivors often suffered multimorbidity. Experts identified 5 groups among those having ≥ 2 chronic conditions: general pediatric morbidity (35.4%); central nervous system (CNS) (22.4%); mental health conditions (22.2%); endocrine (26.2%); and CNS with endocrine (3.8%). The highest expenditures were reported in the CNS group, at $17,964 more per year vs survivors without chronic conditions. As for an emergency department visit, the highest odds were reported in the CNS group. The highest odds of hospitalization were noted in the endocrine group. Overall, 5 different comorbidity subgroups with high yet differential rates of healthcare use were revealed in this study.